Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
Erina Sugita, Kaori Hayashi, Akihito Hishikawa, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23

Showing 23 citing articles:

Diabetic Proteinuria Revisited: Updated Physiologic Perspectives
Samuel N. Heyman, Itamar Raz, Jamie P. Dwyer, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2917-2917
Open Access | Times Cited: 38
Epigenetics in Obesity and Diabetes Mellitus: New Insights
Rosario Suárez, Sebastián Pablo Chapela, Ludwig Roberto Álvarez Córdova, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 811-811
Open Access | Times Cited: 36
Oxidative stress as a culprit in diabetic kidney disease
Sensen Su, Zhanchuan Ma, Hao Wu, et al.
Life Sciences (2023) Vol. 322, pp. 121661-121661
Closed Access | Times Cited: 26
A Narrative Review of New Treatment Options for Diabetic Nephropathy
Aadhira Pillai, Darshna Gulabrao Fulmali
Cureus (2023)
Open Access | Times Cited: 16
Safranal Ameliorates Renal Damage, Inflammation, and Podocyte Injury in Membranous Nephropathy via SIRT/NF-κB Signalling
Yan Bao, Ya-mei Ge, Zhengtao Wang, et al.
Current Medical Science (2025)
Open Access
Renoprotective Effect of Isoorientin in Diabetic Nephropathy via Activating Autophagy and Inhibiting the PI3K-AKT-TSC2-mTOR Pathway
Zili Kong, Min Xiao, Bin Wang, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 05, pp. 1269-1291
Closed Access | Times Cited: 11
Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease
Xian Wang, Xue-qi Liu, Ling Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 321, pp. 121643-121643
Closed Access | Times Cited: 9
Zinc oxide nanoparticles prevent the onset of diabetic nephropathy by inhibiting multiple pathways associated with oxidative stress
Aishwarya Padhye‐Pendse, Rinku D Umrani, Kishore M. Paknikar, et al.
Life Sciences (2024) Vol. 347, pp. 122667-122667
Closed Access | Times Cited: 3
Enhanced Biohomogeneous Composite Membrane-Encapsulated Nanoplatform with Podocyte Targeting for Precise and Safe Treatment of Diabetic Nephropathy
Kui Fan, Shiyi Yuan, Mi Zhou, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 18037-18054
Closed Access | Times Cited: 7
Promoting mitochondrial dynamics by inhibiting the PINK1–PRKN pathway to relieve diabetic nephropathy
Jun‐yi Zhu, Joyce van de Leemput, Zhe Han
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 2
Urolithin A Ameliorates the TGF Beta-Dependent Impairment of Podocytes Exposed to High Glucose
Barbara Lewko, Milena Wodzińska, Agnieszka Daca, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 914-914
Open Access | Times Cited: 2
Integrating the metabolic and molecular circuits in diabetes, obesity and cancer: a comprehensive review
Shweta Anand, Trupti Patel
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Bibliometric Study of Trends in the Diabetic Nephropathy Research Space from 2016 to 2020
Ying Shao
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 11
DNA-damaged podocyte-CD8 T cell crosstalk exacerbates kidney injury by altering DNA methylation
Ran Nakamichi, Akihito Hishikawa, Shunsuke Chikuma, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112302-112302
Open Access | Times Cited: 6
Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway
Lulu Han, Shenghai Wang, Juan Li, et al.
Experimental and Molecular Pathology (2023) Vol. 134, pp. 104877-104877
Open Access | Times Cited: 6
Decrypting the circular RNAs does a favor for us: Understanding, diagnosing and treating diabetes mellitus and its complications
Zi Li, Yuanyuan Ren, Ziwei Lv, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115744-115744
Open Access | Times Cited: 4
Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications
Yi Chen, Yashpal S. Kanwar, Xueqin Chen, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 6, pp. 697-725
Closed Access | Times Cited: 3
Exosomal microRNAs: Potential Nanotherapeutic Targets for Diabetic Kidney Disease
Lulu Han, Xiaoning Cai, Hong Zhou
Nanomedicine (2023) Vol. 18, Iss. 23, pp. 1669-1680
Closed Access | Times Cited: 3
Tanshinone IIA Promoted Autophagy and Inhibited Inflammation to Alleviate Podocyte Injury in Diabetic Nephropathy
Yuan Li, Tong Wu, Hongye Li, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 2709-2724
Open Access
Implications of MCU complex in metabolic diseases
Chen Li, Jiyu Sun, Xidan Zhang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 1
Insights into the Therapeutic Potential of Phytoconstituents as an Epigenetic Modulators in Diabetic Nephropathy
Komal Thapa, Heena Khan, Amarjot Kaur Grewal, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 6, pp. 404-426
Closed Access | Times Cited: 1
Protective Effect of Astragaloside IV against Cadmium-Induced Damage on Mouse Renal Podocytes (MPC5)
Pin Gong, Yue Shan, Fuxiong Shi, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4897-4897
Open Access
Page 1

Scroll to top